dr. liu on parp inhibitors in recurrent ovarian cancer
Published 5 years ago • 194 plays • Length 1:47Download video MP4
Download video MP3
Similar videos
-
1:38
dr. liu on cediranib/olaparib in recurrent ovarian cancer
-
6:20
parp inhibitors in recurrent ovarian cancer
-
11:05
parp inhibitors in recurrent ovarian cancer
-
3:06
recurrent ovarian cancer: choosing a parp inhibitor
-
7:34
parp inhibition’s role in recurrent ovarian cancer
-
1:25
dr. konecny on the indications for parp inhibitors in recurrent ovarian cancer
-
0:58
dr. crafton on the impact of parp inhibitors in recurrent ovarian cancer
-
1:23
dr. liu on phase 2 study results of adavosertib in recurrent uterine serous carcinoma
-
3:25
ovarian cancer: recurrence after parp inhibition
-
1:24
dr. ledermann on response to rucaparib in recurrent ovarian cancer
-
6:50
recurrent ovarian cancer: parp inhibitors compared
-
1:32
dr. campos discusses differences between parp inhibitors in recurrent ovarian cancer
-
1:08
dr. essel on repeat use of parp inhibitors in ovarian cancer
-
1:37
dr. konecny on the use of parp inhibitors in patients with ovarian cancer
-
1:18
dr. backes on treatment selection with parp inhibitors in ovarian cancer
-
2:03
dr. moore on treatment for patients with ovarian cancer who develop resistance to parp inhibitors
-
6:35
parp inhibitor side effect management in ovarian cancer
-
59:14
parp inhibitors in ovarian cancer: clinical updates from sgo 2023
-
2:23
dr. moore on unanswered questions with parp inhibitors in ovarian cancer